[Federal Register Volume 67, Number 109 (Thursday, June 6, 2002)]
[Notices]
[Pages 39029-39030]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-14114]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Training and Career Development.
    Date: June 26, 2002.
    Time: 3:30 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Residence Inn, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Khursheed Asghar, PhD, Chief, Basic Sciences 
Review Branch, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-
2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Transdisciplinary Prevention Research Centers.
    Date: July 10-11, 2002.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 
Bethesda, MD 20814.
    Contact Person: Marina L. Volkov, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1433.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Using

[[Page 39030]]

Basic Science to Develop New Directions in Drug Abuse Prevention 
Research.
    Date: July 16-17, 2002.
    Time: 8:30 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton-Pentagon City, 1250 South Hayes Street, 
Arlington, VA 22202.
    Contact Person: Marina L. Volkov, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1433.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, New Approaches to Prevent HIV/Other Infections in 
Drug Users.
    Date: July 30, 2002.
    Time: 8:30 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Ritz-Carlton-Pentagon City, 1250 South Hayes Street, 
Arlington, VA 22202.
    Contact Person: Kesinee Nimit, MD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1432.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Hepatitis C Diagnosis, Treatment, and Interaction 
with HIV/AIDS.
    Date: August 1-2, 2002.
    Time: 8:30 a.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton-Pentagon City, 1250 South Hayes Street, 
Arlington, VA 22202.
    Contact Person: Rita Liu, PhD, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1388.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: May 30, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-14114 Filed 6-5-02; 8:45 am]
BILLING CODE 4140-01-M